AU1208999A - Compounds which inhibit tryptase activity - Google Patents

Compounds which inhibit tryptase activity

Info

Publication number
AU1208999A
AU1208999A AU12089/99A AU1208999A AU1208999A AU 1208999 A AU1208999 A AU 1208999A AU 12089/99 A AU12089/99 A AU 12089/99A AU 1208999 A AU1208999 A AU 1208999A AU 1208999 A AU1208999 A AU 1208999A
Authority
AU
Australia
Prior art keywords
compounds
tryptase activity
inhibit tryptase
inhibit
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU12089/99A
Other languages
English (en)
Inventor
Laurence Burgess
James P. Rizzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Array Biopharma Inc
Original Assignee
Array Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Array Biopharma Inc filed Critical Array Biopharma Inc
Publication of AU1208999A publication Critical patent/AU1208999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/08—Hydrogen atoms or radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU12089/99A 1997-11-10 1998-11-03 Compounds which inhibit tryptase activity Abandoned AU1208999A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6515497P 1997-11-10 1997-11-10
US60065154 1997-11-10
US17969598A 1998-10-27 1998-10-27
US09179695 1998-10-27
PCT/US1998/023362 WO1999024407A1 (fr) 1997-11-10 1998-11-03 Composes inhibant l'activite de la tryptase

Publications (1)

Publication Number Publication Date
AU1208999A true AU1208999A (en) 1999-05-31

Family

ID=26745272

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12089/99A Abandoned AU1208999A (en) 1997-11-10 1998-11-03 Compounds which inhibit tryptase activity

Country Status (3)

Country Link
EP (1) EP1030844A1 (fr)
AU (1) AU1208999A (fr)
WO (1) WO1999024407A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0896533T3 (da) 1996-02-22 2004-01-26 Tularik Inc Pentafluorbenzensulfonamider og analoger
CN1147294C (zh) 1996-07-19 2004-04-28 图拉列克股份有限公司 五氟苯磺酰胺及其类似物
HUP0103884A3 (en) 1998-09-23 2002-11-28 Tularik Inc South San Francisc Arylsulfonanilide urea-derivatives, pharmaceutical compositions containing them and their use
AU5102800A (en) * 1999-05-31 2000-12-18 Daiichi Pharmaceutical Co., Ltd. Remedies for periodontal diseases
US6541486B1 (en) * 1999-06-04 2003-04-01 Elan Pharma International Ltd. Bis-benzimidazole compounds and analogs thereof for inhibiting cell death
JP2003509417A (ja) 1999-09-14 2003-03-11 アルタナ ファルマ アクチエンゲゼルシャフト トリプターゼインヒビター
US6413990B1 (en) 1999-09-24 2002-07-02 Boehringer Ingelheim Pharma Kg Arylsulphonamide-substituted benzimidazoles having tryptase-inhibiting activity
MXPA02002622A (es) * 1999-09-24 2002-10-24 Boehringer Ingelheim Pharma Derivados de bencimidazol sustituidos con arilsulfonamida, procedimiento para su preparacion y su empleo como medicamentos.
DE19945787A1 (de) 1999-09-24 2001-03-29 Boehringer Ingelheim Pharma Arylsulfonamid-substituierte Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19945810A1 (de) * 1999-09-24 2001-03-29 Boehringer Ingelheim Pharma Substituierte Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
GB9923710D0 (en) * 1999-10-08 1999-12-08 Proteus Molecular Design Chemical compounds
TR200402164T4 (tr) 1999-12-20 2004-10-21 Altana Pharma Ag Triptaz inhibitörler
CA2438594A1 (fr) 2001-01-31 2002-08-08 Altana Pharma Ag Derives de diazocine et leur utilisation en tant qu'inhibiteurs de tryptase
DE10105628A1 (de) * 2001-02-08 2002-08-22 Boehringer Ingelheim Pharma Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US6656956B2 (en) 2001-02-08 2003-12-02 Boehringer Ingelheim Pharma Kg Benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions
WO2002066420A2 (fr) 2001-02-21 2002-08-29 Altana Pharma Ag Inhibiteurs de la tryptase
CA2438685A1 (fr) 2001-02-21 2002-08-29 Altana Pharma Ag Inhibiteurs de tryptase
ATE348803T1 (de) 2001-06-19 2007-01-15 Altana Pharma Ag Tryptase-inhibitoren
JP2005523883A (ja) * 2001-12-13 2005-08-11 興和株式会社 遅延型過敏症予防・治療用医薬組成物
US7049333B2 (en) 2002-06-04 2006-05-23 Sanofi-Aventis Deutschland Gmbh Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU527371B2 (en) * 1980-09-16 1983-03-03 Torii & Co., Ltd. Amidine
DE3427865A1 (de) * 1984-07-27 1986-02-06 Torii & Co., Tokio/Tokyo Amidinoverbindungen, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische mittel
US5481021A (en) * 1991-03-06 1996-01-02 G. D. Searle & Co. Phenyl amidines derivatives useful as platelet aggregation inhibitors
ZA928276B (en) * 1991-10-31 1993-05-06 Daiichi Seiyaku Co Aromatic amidine derivates and salts thereof.
JPH05213927A (ja) * 1992-02-10 1993-08-24 Torii Yakuhin Kk 新規フランカルボン酸アミジノナフチルエステル誘導体およびその酸付加塩
US5525623A (en) * 1993-03-12 1996-06-11 Arris Pharmaceutical Corporation Compositions and methods for the treatment of immunomediated inflammatory disorders
UA42719C2 (uk) * 1993-03-12 2001-11-15 Аксіз Фармасьютікелз, Інк Сполуки, композиції та способи, які інгібують протеази, для лікування та профілактики імуномедіаторних запальних хвороб
DE4316922A1 (de) * 1993-05-20 1994-11-24 Boehringer Mannheim Gmbh Neue 4-Amidinophenylsulfonamide - Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
EP0782571A1 (fr) * 1994-09-23 1997-07-09 Arris Pharmaceutical Corporation Compositions et procedes de traitement de maladies inflammatoires provoquees par les mastocytes
CA2208032C (fr) * 1995-01-05 2003-12-23 Torii Pharmaceutical Co., Ltd. Derives d'ester d'amidinonaphtyle substitues
WO1997037969A1 (fr) * 1996-04-10 1997-10-16 Ono Pharmaceutical Co., Ltd. Inhibiteur de tryptase derives de guanidino
WO1998001428A1 (fr) * 1996-07-08 1998-01-15 Du Pont Pharmaceuticals Company AMIDINOINDOLES, AMIDINOAZOLES ET LEURS ANALOGUES AGISSANT EN TANT QU'INHIBITEURS DU FACTEUR Xa ET DE LA THROMBINE

Also Published As

Publication number Publication date
WO1999024407A1 (fr) 1999-05-20
EP1030844A1 (fr) 2000-08-30

Similar Documents

Publication Publication Date Title
AU1208999A (en) Compounds which inhibit tryptase activity
ZA9811915B (en) Fungicidal compounds.
AU6804098A (en) Triazinylaminostilbene compounds
PL338791A1 (en) Compounds exhibiting neuronic activity
AU1301299A (en) Compounds which inhibit tryptase activity
ZA9810766B (en) Novel compounds having cgmp-pde inhibitory activity
AU7476598A (en) 18-substituted-19-nor-vitamin d compounds
ZA983235B (en) Fungicidal active compound combinations
AUPP042397A0 (en) 5-arylpyrazole compounds
AU7124598A (en) Polymer-platinum compounds
AU8997498A (en) Tryptase inhibitor
AU8018798A (en) Fungicidal mixtures
AU6040298A (en) Fungicidal mixtures
AU8017798A (en) Fungicidal mixtures
EP0999205A4 (fr) Composes d'aminocycloalcane
AU8019998A (en) Fluoromethoximino compounds
AU7766598A (en) Fungicidal mixtures
AU8017898A (en) Fungicidal mixtures
AU7912998A (en) Fungicidal mixtures
AUPO733397A0 (en) Pesticidal compounds
GB9704522D0 (en) Compounds
AU7041098A (en) Pi-complex compounds
AU9753998A (en) Azaboroxine compounds
AU7039898A (en) Fungicidal methoximinomethyldioxazines
AU9811598A (en) Fungicidal mixtures

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase